VBI Vaccines Inc. (NASDAQ: VBIV)
$0.76
-0.0268 ( -3.41% ) 85.8K
VBI Vaccines Inc is a commercial-stage, the biopharmaceutical company which is engaged in developing next-generation vaccines to address unmet needs in infectious disease and immuno-oncology. The company manufactures Sci-B-Vac product which is a hepatitis B (HBV) vaccine for adults, children, and newborns. Its products include Virus-Like Particle which is vaccine platform which allows for the design of enveloped virus-like particle vaccines that closely mimic the target viruses. The company operates through the single segment being Developing vaccines to address unmet needs in infectious disease and immuno-oncology.
Market Data
Open
$0.76
Previous close
$0.79
Volume
85.8K
Market cap
$21.87M
Day range
$0.74 - $0.79
52 week range
$0.45 - $1.53
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 15 | Jun 25, 2024 |
8-k | 8K-related | 15 | May 29, 2024 |
8-k | 8K-related | 13 | May 24, 2024 |
10-q | Quarterly Reports | 87 | May 15, 2024 |
8-k | 8K-related | 20 | May 15, 2024 |
8-k | 8K-related | 13 | May 01, 2024 |
def | Proxies and info statements | 12 | Apr 29, 2024 |
ars | Annual reports | 1 | Apr 29, 2024 |
8-k | 8K-related | 15 | Apr 16, 2024 |
10-k | Annual reports | 122 | Apr 16, 2024 |